SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors closely monitor reports that the pivotal Phase 3 REGAL trial has reached its 80th event, a key milestone for final efficacy analysis. While the community is debating the potential for a breakthrough AML treatment and possible pharmaceutical interest, retail sentiment remains split between bullish enthusiasm and skepticism regarding unconfirmed reports.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending following a significant equity capital raise aimed at bolstering its AI infrastructure, which has triggered mixed reactions and dilution concerns among investors. While the community is actively debating the trade-offs between long-term AI competitiveness and immediate shareholder dilution, the stock remains a central focus as traders look toward upcoming earnings.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate its utility in payment infrastructure versus ongoing price stagnation, with sentiment divided between those aggressively accumulating the dip and others calling the project a scam.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending after announcing a major custom AI chip partnership with Google, which includes a warrant agreement tied to future revenue targets. Retail traders are actively discussing the stock's volatility and its potential for a significant rally leading into the upcoming earnings report.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Investors are closely watching Subsquid (SQD) for its role as a high-performance decentralized data layer for AI and blockchain applications, with many discussing its potential to outperform competitors like The Graph. Community sentiment is mixed between optimism for upcoming institutional partnerships and infrastructure scalability, and skepticism regarding token price action and the impact of its acquisition by Rezolve AI.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is facing a sharp sell-off as investors react to a newly announced $600 million at-the-market equity offering, fueling widespread concerns over potential share dilution. While community sentiment is currently bearish, some market participants argue the capital raise is a strategic move to fund manufacturing expansion and meet high AI-driven demand for optical transceivers.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is surging as community sentiment remains highly bullish amid the latest Bitcoin price rally and increased institutional focus on digital assets. Investors are closely monitoring its performance as a primary vehicle for exposure to current market momentum.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors monitor ongoing defense contracts and the company's strategic pivot toward AI infrastructure, particularly its Neural I/o technology. The community is actively discussing potential buyout interest and the impact of the company's expansion into new design centers on future revenue.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently in the spotlight as investors anticipate Phase 3 trial results for its lead depression drug, HLP003, with the community actively debating whether the stock's significant undervaluation compared to sector peers makes it a prime candidate for acquisition or if ongoing management volatility and dilution risks remain too high. The conversation is heavily focused on the stock's clinical potential as an adjunctive treatment and its long-term durability data, which proponents argue positions it for a major valuation re-rating by year-end.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is facing investor scrutiny following a series of analyst price target cuts across the SMR sector, even as the company continues to advance its KRONOS micro-modular reactor and collaboration efforts in the nuclear fuel supply chain. Community discourse remains polarized, with some bulls highlighting the potential for long-term growth driven by AI data center energy needs, while skeptics focus on valuation concerns and the pre-revenue nature of the business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates

Cerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

This account has been verified as an official CNSY representative.

Verified Account

Cerenome

Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Cerenome Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.07
Prev Close	$3.00
Open	$3.04
Dividend Yield	0.00%
50-Day Moving Average	$3.94
Beta	1.37
Avg. Volume	122,392.00
PE Ratio	-0.70

52-Week High	$23.43
52-Week Low	$2.90
Market Capitalization	$23.3M
EPS (Annual)	-$7.19
Price to Book	4.11
Revenue Per Employee	$186,178.57

Feed

News

Sentiment

Fundamentals

Info